)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
TherapeuticsMD
TherapeuticsMD (TXMD) investor relations material
TherapeuticsMD Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary30 Mar, 2026
Executive summary
Reported a net loss from continuing operations of $(0.7) million for 2025, improving by $1.7 million year-over-year.
License revenue increased 71.6% to $3.0 million, primarily from the Mayne License Agreement.
Operating expenses decreased by 5.9% to $7.4 million, mainly due to lower impairment charges.
Cash and cash equivalents stood at $7.5 million as of December 31, 2025.
Outlook and guidance
Actively evaluating strategic alternatives, including potential acquisitions, mergers, or asset sales, with no set timetable for completion.
No further updates on strategic review will be provided unless deemed necessary.
Key financial ratios and metrics
Net loss per basic and diluted share improved to $(0.06) from $(0.20) year-over-year.
License revenue growth of $1.3 million year-over-year.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from TherapeuticsMD
- Stockholders will vote on director elections, executive pay, auditor ratification, and a large share increase.TXMD
Proxy Filing1 Dec 2025 - Annual meeting to vote on directors, executive pay, and auditor, with strong governance and ESG focus.TXMDProxy Filing1 Dec 2025
- Virtual annual meeting to elect directors, approve compensation, and increase share authorization.TXMDProxy Filing1 Dec 2025
- Shareholders to vote on director elections, executive pay, and auditor ratification at virtual meeting.TXMDProxy Filing1 Dec 2025
- Profitability returned in Q3 2025, but legal and liquidity risks threaten future viability.TXMDQ3 202513 Nov 2025
- Annual meeting to vote on directors, compensation, auditor, and a 20x increase in authorized shares.TXMDProxy Filing3 Nov 2025
- Net loss improved and costs fell, but license revenue dropped and liquidity risks remain.TXMDQ2 202417 Oct 2025
- Profitability returned in Q2 2025, but legal and liquidity risks threaten future operations.TXMDQ2 202512 Aug 2025
- Net loss narrowed and license revenue rose, but going concern risk persists.TXMDQ3 202413 Jun 2025
Next TherapeuticsMD earnings date
Q1 202612 May, 2026
TherapeuticsMD
Next TherapeuticsMD earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage